Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-77,394
Closed -$13.2M 31
2024
Q3
$13.2M Buy
77,394
+74,966
+3,088% +$10.9M 3.13% 20
2024
Q2
$343K Hold
2,428
0.09% 27
2024
Q1
$305K Buy
+2,428
New +$278K 0.08% 28
2018
Q1
Sell
-59,434
Closed -$2.81M 39
2017
Q4
$2.81M Sell
59,434
-93,107
-61% -$4.57M 1.42% 28
2017
Q3
$7.38M Buy
152,541
+120,295
+373% +$5.99M 3.81% 5
2017
Q2
$1.62M Buy
+32,246
New +$1.47M 0.8% 38

Other funds holding ORCL

Nepsis Inc's ORCL Position: Q4 2024 in Review

Nepsis Inc sold out of Oracle (ORCL) in Q4 2024, closing a stake of 77,394 shares — an estimated $13.2M sold.

Nepsis Inc first reported a position in ORCL in Q2 2017 and held it in 6 quarters. The position peaked at $13.2M in Q3 2024. 3,343 funds tracked by Wall St. Rank hold ORCL as of Q4 2024.

  • Nepsis Inc reported no remaining Oracle position as of Q4 2024 after selling out during the quarter.
  • Nepsis Inc sold 77,394 Oracle shares in Q4 2024, an estimated $13.2M.
  • Nepsis Inc first reported a position in Oracle in Q2 2017 and held it in 6 quarters.
  • Nepsis Inc's Oracle position peaked at $13.2M in Q3 2024.
  • 3,343 funds tracked by Wall St. Rank held Oracle as of Q4 2024.

Based on Nepsis Inc's 13F filing for Q4 2024, filed 21 Jan 2025.